Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
A reduced sympathoadrenal response, induced by recent antecedent hypoglycemia, is the key feature of hypoglycemia-associated autonomic failure (HAAF) and, thus, the pathogenesis of iatrogenic hypoglycemia in diabetes. Understanding of the mechanism(s) of that reduced response awaits new insight into its basic molecular, cellular, organ, and whole-body physiology and pathophysiology in experimental models. In this issue of the JCI, McCrimmon and colleagues report that application of urocortin I (a corticotrophin-releasing factor receptor-2 agonist) to the ventromedial hypothalamus reduces the glucose counterregulatory response to hypoglycemia in rats (see the related article beginning on page 1723). Thus, hypothalamic urocortin I release during antecedent hypoglycemia is, among other possibilities, a potential mechanism of HAAF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Self-citationDagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Self-citationDiverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411
Self-citationHypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337
Self-citationRaju, B., & Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.3.757 · Cited by 155
Self-citationActivation of human medial prefrontal cortex during autonomic responses to hypoglycemia
Teves, D., Videen, T. O., Cryer, P. E., & Powers, W. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307048101 · Cited by 138
Self-citationDeRosa, M. A., & Cryer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00539.2003 · Cited by 126
Self-citation
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Self-citationClassification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus
Baynest, H. W. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000541 · Cited by 373
Brain Glucose Sensing, Counterregulation, and Energy Homeostasis
Marty, N., Dallaporta, M., & Thorens, B. (2007) · Physiology · doi:10.1152/physiol.00010.2007 · Cited by 328
The Cells of the Islets of Langerhans
Da Silva Xavier, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030054 · Cited by 295
Leptin revisited: its mechanism of action and potential for treating diabetes
Coppari, R., & Bjørbæk, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3757 · Cited by 293
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
Halter, J. B., Musi, N., McFarland Horne, F., Crandall, J. P., Goldberg, A., Harkless, L., Hazzard, W. R., Huang, E. S., Kirkman, M. S., Plutzky, J., et al. (2014) · Diabetes · doi:10.2337/db14-0020 · Cited by 255
“Hypoglycemia increases QTc interval, production of proinflammatory markers, platelet activation, and markers of oxidative stress, and it decreases endothelial function and myocardial blood flow (3,45).”
BackgroundClinical experience with tight glucose control by intensive insulin therapy
Preiser, J.-C., & Devos, P. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000278046.24345.c7 · Cited by 253
Hypoglycemia in Type 1 Diabetes Mellitus
Cryer, P. E. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.003 · Cited by 205
“All of these defenses are typically compromised in people with T1DM [1,2,20,21].”
BackgroundSelf-citationBrain glucose sensing and neural regulation of insulin and glucagon secretion
Thorens, B. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01453.x · Cited by 198
“Interestingly, the corticotrophinreleasing factors (CRF) and urocortin I, which are agonists of the CRF receptor 1 and 2, respectively, either increase or, respectively, suppress hypoglycemia-induced counterregulation by directly modulating the firing rate of the glucose sensitive VMH neurons [40,41].”
BackgroundNeural regulation of pancreatic islet cell mass and function
Thorens, B. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12346 · Cited by 140
Lamy, C. M., Sanno, H., Labouèbe, G., Picard, A., Magnan, C., Chatton, J.-Y., & Thorens, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.003 · Cited by 130
“This is an important step in elucidating not only the mechanisms controlling stimulated glucagon secretion in physiological conditions, but also when this secretion becomes unresponsive to developing hypoglycemia, as associated with hypoglycemia-associated autonomic failure (Cryer, 2006), a serious condition that limi…”
BackgroundAttenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition
Arbelaez, A. M., Powers, W. J., Videen, T. O., Price, J. L., & Cryer, P. E. (2008) · Diabetes · doi:10.2337/db07-1329 · Cited by 92
Self-citationLin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
Karimian, N., Qin, T., Liang, T., Osundiji, M., Huang, Y., Teich, T., Riddell, M. C., Cattral, M. S., Coy, D. H., Vranic, M., et al. (2013) · Diabetes · doi:10.2337/db13-0164 · Cited by 66
Stress, hypoglycemia, and the autonomic nervous system
Haas, A., Borsook, D., Adler, G., & Freeman, R. (2022) · Autonomic Neuroscience · doi:10.1016/j.autneu.2022.102983 · Cited by 30
Continuous glucose monitoring reveals associations of glucose levels with QT interval length
Kubiak, T., Wittig, A., Koll, C., Mraz, B., Gustav, J., Herrmann, U., Weber, H., & Kerner, W. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0153 · Cited by 28
“…a structured inter-view based on the validated questionnaire by Clarke et al. 12 Impaired hypoglycemia awareness served as a proxy for hypoglycemia-associated failure, 13 a syndrome characterized by diminished autonomic responses towards hypoglycemic states, which could influence QT interval length.”
Seaquist, E. R., Moheet, A., Kumar, A., Deelchand, D. K., Terpstra, M., Kubisiak, K., Eberly, L. E., Henry, P.-G., Joers, J. M., & Öz, G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00477 · Cited by 19
van Beers, C. A. J., Caris, M. G., DeVries, J. H., & Serné, E. H. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.09.005 · Cited by 11
“This has been attributed in part to more heavily affected counterregulatory mechanisms in the latter.(20) In our trial, duration of diabetes was not associatedwith neither severe hypoglycemia, nor the frequency of CGM-assessed hypoglycemic events b2.”
Background
Metadata
- Authors
- Cryer, P. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1470-1473
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2104665577
- Cited by
- 99
- References
- 8
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.